Back to Northern Trust Corp. Northern Trust Corp.

SKYE

Showing 8 of 9 quarters

Position history for Northern Trust Corp.Northern Trust Corp.'s holdings in Skye Bioscience, Inc.

Yes. Northern Trust holds 56,327 shares of SKYE (Skye Bioscience), worth $39,052, as of its Q2 2026 13F filing. It increased the position by 36,185 shares (+179.7%) from Q1 2026. Northern Trust has held SKYE in every 13F on record since Q2 2024, 9 quarterly filings.

Current Value

$39,052

Current Shares

56,327

Total Value Change

-$511,797

Total Shares Change

-84,555

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
56,327
+179.7%
$39,0520.0%$5.54
22
2026-Q1
Unchanged
20,142
0.0%
$12,3790.0%$4.92
0
2025-Q4
Decreased
20,142
-30.6%
$15,1000.0%$6.00
0
2025-Q3
Unchanged
29,004
0.0%
$113,9860.0%$31.44
0
2025-Q2
Decreased
29,004
-78.9%
$121,2360.0%$33.44
0
2025-Q1
Increased
137,567
+1.4%
$218,7310.0%$12.72
16
2024-Q4
Decreased
135,712
-3.7%
$384,0650.0%$22.64
0
2024-Q3
Increased
140,882
+231.7%
$550,8490.0%$31.28
39

Other major holders of SKYE: BlackRock Finance, Inc., Janus Henderson Group Ltd., Baker Bros. Advisors LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used